Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
12.06. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
21.05. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
13.05. | QT Imaging Holdings GAAP EPS of -$0.40, revenue of $2.8M | 1 | Seeking Alpha | ||
QT IMAGING Aktie jetzt für 0€ handeln | |||||
13.05. | QT Imaging announces $200,000 PIPE investment | 2 | Seeking Alpha | ||
13.05. | QT IMAGING HOLDINGS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
13.05. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
23.04. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
10.04. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
31.03. | QT Imaging Holdings GAAP EPS of -$0.15 | 1 | Seeking Alpha | ||
31.03. | QT IMAGING HOLDINGS, INC. - 10-K, Annual Report | 2 | SEC Filings | ||
31.03. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
28.02. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
27.02. | QT Imaging receives $10.1M in new funding | 1 | Seeking Alpha | ||
12.02. | QT IMAGING HOLDINGS, INC. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
05.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 05.02.2025 | 964 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 05.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 05.02.2025ISIN NameCA75525M1095 RAZOR... ► Artikel lesen | |
31.01. | QT IMAGING HOLDINGS, INC. - S-1/A, General form for registration of securities | - | SEC Filings | ||
24.01. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
13.11.24 | QT Imaging Announces Third Quarter 2024 Financial Results | 209 | Business Wire | NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative... ► Artikel lesen | |
08.08.24 | QT Imaging Announces Second Quarter 2024 Financial Results | 259 | Business Wire | NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
INTUITIVE SURGICAL | 440,20 | -0,09 % | Intuitive Surgical, Inc.: Intuitive demonstrates telesurgery capabilities | SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, has today demonstrated... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,095 | -2,56 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,800 | +4,30 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
PING AN HEALTHCARE | 1,046 | -1,60 % | PA GOODDOCTOR (01833): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | ||
CO-DIAGNOSTICS | 0,228 | 0,00 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
CYTOSORBENTS | 0,900 | -0,33 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
VERU | 0,512 | -0,49 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen | |
VOLITIONRX | 0,684 | 0,00 % | VolitionRx - Nu.Q advances in lung cancer management | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | |
EKSO BIONICS | 3,320 | +3,11 % | XFRA 23E0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILEKSO BIONICS. NEW... ► Artikel lesen | |
IMUNON | 0,464 | +9,95 % | Imunon, Inc.: IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan | Management provides Nasdaq Hearing Panel with a comprehensive executable plan for long term compliance LAWRENCEVILLE, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage... ► Artikel lesen | |
BEYOND AIR | 2,600 | 0,00 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS52110H1005 Lazydays Holdings Inc. 11.07.2025 US52110H2094 Lazydays Holdings Inc. 14.07.2025 Tausch 30:1US08862L1035 Beyond... ► Artikel lesen | |
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
NOVACYT | 0,466 | -2,31 % | Novacyt S.A. - Launch of LightBench® Discover | ||
AROVELLA THERAPEUTICS | 0,050 | -3,85 % | AROVELLA THERAPEUTICS LIMITED: Notification regarding unquoted securities - ALA |